Paid Clinical Trials in Tucson, AZ
As of June 2026, 526 paid clinical trials are recruiting in Tucson, Arizona. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Tucson offers studies at sites including University of Arizona for conditions such as Breast Cancer, Acute Myeloid Leukemia, Breast Neoplasms, Heart Failure. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Tucson
Filter results
0 clinical trials
·Clear filters·↓ Download CSVAbout research studies in Tucson
Tucson has approximately 526 recruiting research studies across a wide range of therapeutic areas. Arizona is home to Mayo Clinic Arizona, Banner - University Medical Center, and TGen (Translational Genomics Research Institute), with active research in oncology and precision medicine.
Top Research Study Locations in Tucson
Researchers run research studies in Tucson, AZ at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Arizona | Amblyopia, Breast Cancer, Aging | 79 |
| Banner University Medical Center - Tucson | Acute Myeloid Leukemia, Acute Myeloid Leukemia Post Cytotoxic Therapy, Recurrent Diffuse Large B-Cell Lymphoma | 61 |
| University of Arizona Cancer Center-North Campus | Acute Myeloid Leukemia, Stage IVB Prostate Cancer AJCC v8, Recurrent Diffuse Large B-Cell Lymphoma | 48 |
| University of Arizona Cancer Center | Breast Cancer, Advanced Solid Tumor, B Cell Lymphoma | 26 |
| The University of Arizona Cancer Center | Advanced Solid Tumor, Breast Cancer, Metastatic Solid Tumor | 13 |
| University of Arizona Cancer Center-Orange Grove Campus | Stage IVB Prostate Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 | 12 |
| Tucson Medical Center | Aortic Valve Stenosis, Mitral Regurgitation, Tricuspid Regurgitation | 9 |
| Banner University Medical Center | Arteriovenous Fistula, Atrial Fibrillation, Catheter Complications | 8 |
| Del Sol Research Management, LLC | Contraception, Influenza, Liver Fibrosis | 8 |
| Pima Heart and Vascular | Heart Failure, Atrial Fibrillation, Deep Venous Thrombosis | 8 |
| GSK Investigational Site | Chickenpox, Breast Neoplasms, Colonic Neoplasms | 7 |
| The University of Arizona Cancer Center - North Campus | Neoplasm Metastasis, Carcinoma, Non-Small-Cell Lung, Acute Myeloid Leukemia Refractory | 7 |
| Center for Neurosciences | Focal Epilepsy, Glioblastoma (GBM), Intermediate Risk Non-Muscle Invasive Bladder Cancer | 6 |
| Noble Clinical Research | Bipolar Depression, Bipolar Disorder, Bipolar I Disorder | 6 |
| Arizona Liver Health - Tucson | Liver Fibrosis, MASH - Metabolic Dysfunction-Associated Steatohepatitis, Metabolic Dysfunction Associated Steatohepatitis | 5 |
| Arizona Oncology Associates | Breast Cancer, Cancer, HER2-negative Breast Cancer | 5 |
| Arizona Urology Specialists | Prostate Cancer, Benign Prostatic Hyperplasia (BPH), Bladder Pain Syndrome | 5 |
| Del Sol Research Management | Major Depressive Disorder, Familial Adenomatous Polyposis, Lower Urinary Tract Symptoms (LUTS) | 5 |
| Arizona Clinical Trials | Obesity or Overweight, Cardiovascular Diseases, Diabetes Mellitus, Type 2 | 4 |
| Eclipse Clinical Research | Cardiovascular Disease, Cardiovascular Disease and Lipoprotein(a), Healthy | 4 |
| Pima Heart & Vascular | Atrial Fibrillation, Coronary Artery Disease, High-Risk Percutaneous Coronary Intervention | 4 |
| Tucson Cystic Fibrosis Center | Cystic Fibrosis, Cystic Fibrosis Lung, Cystic Fibrosis Pulmonary Exacerbation | 4 |
| University of Arizona Cancer Center - Prevention Research Clinic | Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Breast Atypical Ductal Hyperplasia | 4 |
| University of Arizona College of Medicine | Cancer, Diabetes, Diabetic Foot | 4 |
| Adobe Clinical Research, LLC | Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis, Metabolic Dysfunction Associated Steatohepatitis (MASH) | 3 |
Active & Upcoming Studies in Tucson (2026)
Recruiting trials in Tucson grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (182 active studies)
- Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS) · Phase 1, Phase 2 · University of Arizona
- A Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer · Phase 1 · University of Wisconsin, Madison
Cardiovascular (35 active studies)
- Tiprelestat Versus Placebo When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH) · Phase 2 · Stanford University
- A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation · Biosense Webster, Inc.
Neurology & pain (34 active studies)
- Hypknowledge Nationwide Sleep Extension · University of Arizona
- Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE) · Phase 3 · Ambros Therapeutics, Inc.
Diabetes & metabolic (29 active studies)
- A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight · Phase 2 · Eli Lilly and Company
- A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes · Phase 3 · Hoffmann-La Roche
Mental health & behavior (8 active studies)
- Service Dogs and Prolonged Exposure Therapy for Military-Connected PTSD · University of Arizona
- A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression) · Phase 3 · Xenon Pharmaceuticals Inc.
Vaccines (4 active studies)
- A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza · Phase 3 · Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Investigating Measurable PRO Acuity Trial (IMPACT) is a Multi-Center Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Maraviroc and Atorvastatin to Improve Neurocognitive and Physical Function of Subjects With Long COVID-19/Post-Acute Sequelae of COVID-19 (PASC). · Phase 2, Phase 3 · HealthBio, Inc.
Eye & vision (3 active studies)
- Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration · Phase 3 · 4D Molecular Therapeutics
- A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy · Phase 3 · Regeneron Pharmaceuticals
Pediatric (2 active studies)
- CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D) · Phase 1, Phase 2 · COUR Pharmaceutical Development Company, Inc.
- A Study to Evaluate Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Participants With Childhood Epilepsy · Phase 2 · Eisai Inc.
HIV / STI (1 active study)
- Wellness Intervention for Smoking and HIV · University of Arizona
Common conditions studied in Tucson
- Breast Cancer (14 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Acute Myeloid Leukemia (8 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Breast Neoplasms (8 active studies). Recruiting Breast Neoplasms studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Heart Failure (7 active studies). Heart failure trials explore SGLT-2 inhibitors, novel myosin modulators, and device-based therapies for both reduced and preserved ejection fraction.
- Obesity (7 active studies). Obesity trials evaluate GLP-1 and GIP receptor agonists, novel metabolic drugs, and combined lifestyle interventions for sustainable weight loss.
- Prostate Cancer (7 active studies). Prostate cancer studies test next-generation hormone therapies, PARP inhibitors, and radioligand treatments for both localized and advanced disease.
Leading research sponsors in Tucson
- University of Arizona
- AstraZeneca
- National Cancer Institute (NCI)
- Eli Lilly and Company
- Merck Sharp & Dohme LLC
Local regulations and guidelines
Clinical trials in Arizona are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Arizona research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Tucson. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Tucson
Hipa.ai aggregates every recruiting study in Tucson from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Tucson?
There are approximately 526 recruiting clinical trials in Tucson, Arizona listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Tucson pay participants?
Most recruiting trials in Tucson compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Tucson?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Tucson?
The most common conditions under active study in Tucson include Breast Cancer (14), Acute Myeloid Leukemia (8), Breast Neoplasms (8), Heart Failure (7), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Tucson?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Tucson on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Tucson?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Tucson?
Recruiting research sites in Tucson include University of Arizona, Banner University Medical Center - Tucson, University of Arizona Cancer Center-North Campus, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Tucson right now?
The largest active categories in Tucson are Cancer & tumors (182), Cardiovascular (35), Neurology & pain (34). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.